Gossamer Bio, Inc. (GOSS)

2.73 -0.14 (-4.88%) USD  |  NASDAQ  |  Jan 23, 11:35
More

Gossamer Bio Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. --
Axsome Therapeutics, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade